Site navigation

Navigation

Lung cancer (non-small-cell) - pemetrexed (maintenance)

Pemetrexed for the maintenance treatment of non-small cell lung cancer

Status: In progress
Expected date of issue: May 2010
Referral date: November 2008
Wave: CRS2
Process: STA
Notes:

Cancer reform strategy batch 2

Topic area:
  • Cancer
  • Respiratory
 

NICE project team

Executive Lead: Gillian Leng
Technical Lead: Raphael Yugi
Communications manager: Alice Law
Project manager: Laura Malone
Evidence review group: Liverpool Reviews and Implementation Group
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 13 August 2009
1st appraisal committee meeting: 11 November 2009
Top


 

Consultees and Commentators

Consultees Commentators (no right to submit or appeal)

Manufacturers/sponsors

  • Eli Lilly & Co. (pemetrexed)

Patient/carer groups

  • Afiya Trust
  • Age Concern England
  • Black Health Agency
  • Breathe Easy
  • British Lung Foundation
  • CANCERactive
  • Cancerbackup
  • Cancer Equality
  • Cancer Voices
  • Chinese National Healthy Living Centre
  • Chronic Lymphocytic Leukaemia Support Association (CLLSA)
  • Confederation of Indian Organisations
  • Counsel and Care
  • Equalities National Council
  • Helen Rollason Heal Cancer Charity
  • Help the Aged
  • Macmillan Cancer Support
  • Maggie’s Centres
  • Marie Curie Cancer Care
  • Muslim Council of Great Britain
  • Muslim Health Network
  • National Cancer Alliance
  • National Council for Palliative Care
  • South Asian Health Foundation
  • Specialised Healthcare Alliance
  • Sue Ryder Care
  • Tenovus Cancer Information Centre
  • UK Transplant

Professional groups

  • Association of Cancer Physicians
  • Association of Respiratory Nurse Specialists
  • British Association for Services to the Elderly
  • British Geriatrics Society
  • British Oncological Association
  • British Psychosocial Oncology Society
  • British Thoracic Society (Lung Cancer and Mesothelioma Working party)
  • Cancer Networks Pharmacists Forum
  • Cancer Research UK
  • General Practice Airways Group
  • National Lung Cancer Forum for Nurses
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians, Medical Oncology Joint Special Committee
  • Royal College of Physicians’ Intercollegiate Lung Cancer Group
  • Royal College of Radiologists
  • Royal Pharmaceutical Society
  • Royal Society of Medicine – Intellectual Disabilities Forum
  • United Kingdom Clinical Pharmacy Association
  • United Kingdom Clinical Pharmacy Association
  • United Kingdom Oncology Nursing Society

Others

  • Department of Health
  • East Sussex Downs and Weald
  • Surrey PCT
  • Welsh Assembly Government
  • Wolverhampton City PCT

General

  • Age Concern Cymru
  • Board of Community Health Councils in Wales
  • British National Formulary
  • Cancer Care Cymru
  • Department of Health, Social Services and Public Safety for Northern Ireland
  • Medicines and Healthcare products Regulatory Agency
  • National Association of Primary Care
  • National Public Health Service for Wales
  • NHS Alliance
  • NHS Confederation
  • NHS Purchasing and Supply Agency
  • NHS Quality Improvement Scotland
  • Scottish Medicines Consortium

Comparator manufacturers

  • None

Relevant research groups

  • British Thoracic Oncology Group
  • Institute of Cancer Research
  • MRC CTU - Lung Cancer and Mesothelioma Group
  • National Cancer Research Institute
  • National Cancer Research Network
  • National Institute of Health Research
  • Policy Research Institute on Ageing and Ethnicity
  • Research Institute for the Care of Older People

Evidence Review Group

  • Liverpool Reviews & Implementation Group, University of Liverpool
  • National Institute for Health Research Health Technology Assessment Programme

Associated Guideline Groups

  • National Collaborating Centre for Cancer

Associated Public Health Groups

  • None

Top


 

Key documents

This page was last updated:   21 December 2009